Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis

BACKGROUND: Inhaled corticosteroids (ICS), especially when prescribed in combination with long-acting β(2) agonists have been shown to improve COPD outcomes. Although there is consistent evidence linking ICS with adverse effects such as pneumonia, the complete risk profile is unclear with conflictin...

Descripción completa

Detalles Bibliográficos
Autores principales: Flynn, Rob W, MacDonald, Thomas M, Hapca, Adrian, MacKenzie, Isla S, Schembri, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239312/
https://www.ncbi.nlm.nih.gov/pubmed/25407604
http://dx.doi.org/10.1186/s12931-014-0141-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239312/
https://www.ncbi.nlm.nih.gov/pubmed/25407604
http://dx.doi.org/10.1186/s12931-014-0141-y

Ejemplares similares